Editas Medicine logo

Editas Medicine Share Price Today

(NASDAQ: EDIT)

Editas Medicine share price is $1.28 & ₹109.40 as on 18 Apr 2025, 2.30 'hrs' IST

$1.28

0.01

(0.79%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Editas Medicine share price in Dollar and Rupees. Guide to invest in Editas Medicine stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Editas Medicine, along with analyst recommendations, forecasts, and comprehensive financials.

Editas Medicine share price movements

  • Today's Low: $1.25
    Today's High: $1.31

    Day's Volatility :4.28%

  • 52 Weeks Low: $0.91
    52 Weeks High: $6.69

    52 Weeks Volatility :86.4%

Editas Medicine (EDIT) Returns

PeriodEditas Medicine Inc.Sector (Health Care)Index (Russel 2000)
3 Months
5.79%
-2.8%
0.0%
6 Months
-65.96%
-11.0%
0.0%
1 Year
-76.68%
-1.9%
0.0%
3 Years
-91.09%
-1.5%
-12.9%

Editas Medicine (EDIT) Key Statistics

in dollars & INR

Previous Close
$1.27
Open
$1.28
Today's High
$1.3059
Today's Low
$1.25
Market Capitalization
$107.1M
Today's Volume
$742.7K
52 Week High
$6.69
52 Week Low
$0.9101
Revenue TTM
$32.3M
EBITDA
$-233.1M
Earnings Per Share (EPS)
$-2.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-98.1%

How to invest in Editas Medicine Stock (EDIT) from India?

It is very easy for Indian residents to invest directly in Editas Medicine from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Editas Medicine stock in both Indian Rupees (INR) and US Dollars (USD). Search for Editas Medicine or EDIT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Editas Medicine or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Editas Medicine shares which would translate to 0.668 fractional shares of Editas Medicine as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Editas Medicine, in just a few clicks!

Returns in Editas Medicine (EDIT) for Indian investors in Rupees

The Editas Medicine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Editas Medicine investment value today

Current value as on today

₹25,656

Returns

₹74,344

(-74.34%)

Returns from Editas Medicine Stock

₹76,685 (-76.68%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Editas Medicine (EDIT)

-46%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Editas Medicine Stock from India on INDmoney has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Editas Medicine

  • BlackRock Inc

    8.81%

  • Vanguard Group Inc

    8.22%

  • Millennium Management LLC

    3.31%

  • Dimensional Fund Advisors, Inc.

    2.60%

  • State Street Corp

    2.26%

  • Geode Capital Management, LLC

    2.18%

Analyst Recommendation on Editas Medicine

Rating
Trend

Buy

    54%Buy

    41%Hold

    4%Sell

Based on 24 Wall street analysts offering stock ratings for Editas Medicine(by analysts ranked 0 to 5 stars)

Analyst Forecast on Editas Medicine Stock (EDIT)

What analysts predicted

Upside of 192.97%

Target:

$3.75

Current:

$1.28

Insights on Editas Medicine Stock (Ticker Symbol: EDIT)

  • Price Movement

    In the last 6 months, EDIT stock has moved down by -62.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 61.0K → 30.60M (in $), with an average increase of 99.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -67.60M → -45.39M (in $), with an average increase of 22.8% per quarter
  • EDIT vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 153.0%
  • EDIT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 120.9%
  • Price to Sales

    ForEDIT every $1 of sales, investors are willing to pay $3.3, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

EDIT Editas Medicine Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$32.3M
↓ 58.64%
Net Income
$-237.1M
↑ 54.74%
Net Profit Margin
-733.72%
↓ 537.59%

Editas Medicine Technicals Summary

Sell

Neutral

Buy

Editas Medicine is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Editas Medicine (EDIT) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Editas Medicine Inc. logo
-7.3%
-65.96%
-76.68%
-91.09%
-94.84%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Editas Medicine

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Organization
Editas Medicine
Employees
246
CEO
Dr. Linda C. Burkly Ph.D.
Industry
Health Technology

Management People of Editas Medicine

NameTitle
Dr. Linda C. Burkly Ph.D.
Executive VP & Chief Scientific Officer
Dr. Feng Zhang Ph.D.
Co-Founder & Scientific Advisory Board Member
Dr. George McDonald Church Ph.D.
Co-Founder & Scientific Advisory Board Member
Mr. Gregory Whitehead
Executive VP and Chief Technical & Quality Officer

Important FAQs about investing in EDIT Stock from India :

What is Editas Medicine share price today?

Editas Medicine share price today stands at $1.28, Open: $1.28 ; Previous Close: $1.27 ; High: $1.31 ; Low: $1.25 ; 52 Week High: $6.69 ; 52 Week Low: $0.91.

The stock opens at $1.28, after a previous close of $1.27. The stock reached a daily high of $1.31 and a low of $1.25, with a 52-week high of $6.69 and a 52-week low of $0.91.

Can Indians buy Editas Medicine shares?

Yes, Indians can invest in the Editas Medicine (EDIT) from India.

With INDmoney, you can buy Editas Medicine at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Editas Medicine at zero transaction cost.

How can I buy Editas Medicine shares from India?

It is very easy to buy Editas Medicine from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Editas Medicine (EDIT) be purchased?

Yes, you can buy fractional shares of Editas Medicine with INDmoney app.

What are the documents required to start investing in Editas Medicine stocks?

To start investing in Editas Medicine, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Editas Medicine Stock (EDIT)?

Today’s highest price of Editas Medicine (EDIT) is $1.31.

Today’s lowest price of Editas Medicine (EDIT) is $1.25.

What is today's market capitalisation of Editas Medicine?

Today's market capitalisation of Editas Medicine EDIT is 107.1M

What is the 52 Week High and Low Range of Editas Medicine Stock (EDIT)?

  • 52 Week High

    $6.69

  • 52 Week Low

    $0.91

What are the historical returns of Editas Medicine (EDIT)?

  • 1 Month Returns

    -7.3%

  • 3 Months Returns

    -65.96%

  • 1 Year Returns

    -76.68%

  • 5 Years Returns

    -94.84%

Who is the Chief Executive Officer (CEO) of Editas Medicine ?

Dr. Linda C. Burkly Ph.D. is the current Chief Executive Officer (CEO) of Editas Medicine.